Teramoto Y A, Meriani R, Wunderlich D, Schlom J
Cancer. 1982 Jul 15;50(2):241-9. doi: 10.1002/1097-0142(19820715)50:2<241::aid-cncr2820500214>3.0.co;2-5.
Human monoclonal antibodies have been generated following the fusion of human lymphocytes (obtained from axillary lymph nodes of mastectomy patients) with a murine nonimmunoglobulin secreting myeloma cell line. We report a detailed analysis of the reactivity of a human IgM monoclonal antibody secreted by one of these double cloned hybridoma cell lines. Tissue sections of both malignant and benign human mammary tumors, as well as apparently normal tissues, were tested using the immunoperoxidase technique and the human monoclonal antibody. Eighty-one per cent (54/67) of primary malignant mammary tumors, 100% (20/20) of metastatic breast lesions, and 14% (3/22) of benign breast lesions reacted positively with a moderate for strong intensity. The per cent of mammary carcinoma cells that stained and the pattern of staining varied among different tumor samples. While reactivity was observed with selected carcinomas of nonbreast origin, little or no reactivity was observed with apparently normal human tissues including normal mammary epithelium. The antibody reactivity observed was shown to be clearly distinct from those of both anti-T and anticarcinoembryonic antigen sera.
通过将人类淋巴细胞(从乳房切除术患者的腋窝淋巴结获取)与一种不分泌免疫球蛋白的鼠骨髓瘤细胞系融合,已产生了人类单克隆抗体。我们报告了对其中一个双克隆杂交瘤细胞系分泌的一种人类IgM单克隆抗体反应性的详细分析。使用免疫过氧化物酶技术和该人类单克隆抗体对人类恶性和良性乳腺肿瘤组织切片以及明显正常的组织进行了检测。81%(54/67)的原发性恶性乳腺肿瘤、100%(20/20)的转移性乳腺病变以及14%(3/22)的良性乳腺病变呈中度至强强度阳性反应。不同肿瘤样本中染色的乳腺癌细胞百分比和染色模式各不相同。虽然在某些非乳腺来源的癌中观察到了反应性,但在包括正常乳腺上皮在内的明显正常人类组织中几乎未观察到反应性。所观察到的抗体反应性明显不同于抗T血清和抗癌胚抗原血清的反应性。